Tandem Diabetes Care, Inc.
NasdaqGM:TNDM
$ 59.54
+ $0.94 (1.60%)
$ 59.54
+ $0.94 (1.60%)
End-of-day quote: 08/05/2022

TNDM - Tandem Diabetes Care Stock Prediction 2025 - 2030

Reliable Tandem Diabetes Care stock prediction from 7 Wall Street analysts. See at a glance if NasdaqGM:TNDM is undervalued and recommended to buy.

$62.15
Forecast 2022
$85.44
Forecast 2025
$145.21
Forecast 2030
Underperform
TopGraphs Quality Ranking
Forecast 2022
$62.15
Forecast 2025
$85.44
Forecast 2030
$145.21
TopGraphs Quality Ranking
Underperform

Tandem Diabetes Care Stock Forecast 2022

$92.00

In the last five quarters, Tandem Diabetes Care's Price Target has fallen from $172.90 to $127.93 - medium decrease of -26.01%. Seven analysts expect Tandem Diabetes Care's share price to fall moderately in the coming year and give 92.00 as a price target. This would correspond to an decrease of -28.09%.

54.52%
54.52

Highest Price Target $150.00

Average Price Target $92.00

Lowest Price Target $49.00

Tandem Diabetes Care Stock Forecast 2025

Stock Prediction for the Price of One Tandem Diabetes Care Share in Jan 2025.

In Jan 2025 analysts predict a share price of $77.56. An increase of 30.26% compared to today's share price.

Stock Prediction for the Price of One Tandem Diabetes Care Share in Feb 2025.

In Feb 2025 analysts predict a share price of $78.27. An increase of 31.46% compared to today's share price.

Stock Prediction for the Price of One Tandem Diabetes Care Share in Mar 2025.

In Mar 2025 analysts predict a share price of $78.99. An increase of 32.67% compared to today's share price.

Stock Prediction for the Price of One Tandem Diabetes Care Share in Apr 2025.

In Apr 2025 analysts predict a share price of $79.71. An increase of 33.87% compared to today's share price.

Stock Prediction for the Price of One Tandem Diabetes Care Share in May 2025.

In May 2025 analysts predict a share price of $80.42. An increase of 35.07% compared to today's share price.

Stock Prediction for the Price of One Tandem Diabetes Care Share in Jun 2025.

In Jun 2025 analysts predict a share price of $81.14. An increase of 36.28% compared to today's share price.

Stock Prediction for the Price of One Tandem Diabetes Care Share in Jul 2025.

In Jul 2025 analysts predict a share price of $81.86. An increase of 37.48% compared to today's share price.

Stock Prediction for the Price of One Tandem Diabetes Care Share in Aug 2025.

In Aug 2025 analysts predict a share price of $82.57. An increase of 38.69% compared to today's share price.

Stock Prediction for the Price of One Tandem Diabetes Care Share in Sep 2025.

In Sep 2025 analysts predict a share price of $83.29. An increase of 39.89% compared to today's share price.

Stock Prediction for the Price of One Tandem Diabetes Care Share in Oct 2025.

In Oct 2025 analysts predict a share price of $84.01. An increase of 41.09% compared to today's share price.

Stock Prediction for the Price of One Tandem Diabetes Care Share in Nov 2025.

In Nov 2025 analysts predict a share price of $84.72. An increase of 42.3% compared to today's share price.

Stock Prediction for the Price of One Tandem Diabetes Care Share in Dec 2025.

In Dec 2025 analysts predict a share price of $85.44. An increase of 43.5% compared to today's share price.

Tandem Diabetes Care Stock Predictions 2030

Tandem Diabetes Care Stock Predictions for Jan 2030.

In January 2030 analysts predict a stock price of $131.81. An increase of 121.38% compared to the previous month's estimate.

Tandem Diabetes Care Stock Predictions for Feb 2030.

In February 2030 analysts predict a stock price of $133.03. An increase of 123.43% compared to the previous month's estimate.

Tandem Diabetes Care Stock Predictions for Mar 2030.

In March 2030 analysts predict a stock price of $134.25. An increase of 125.47% compared to the previous month's estimate.

Tandem Diabetes Care Stock Predictions for Apr 2030.

In April 2030 analysts predict a stock price of $135.46. An increase of 127.52% compared to the previous month's estimate.

Tandem Diabetes Care Stock Predictions for May 2030.

In May 2030 analysts predict a stock price of $136.68. An increase of 129.56% compared to the previous month's estimate.

Tandem Diabetes Care Stock Predictions for Jun 2030.

In June 2030 analysts predict a stock price of $137.90. An increase of 131.61% compared to the previous month's estimate.

Tandem Diabetes Care Stock Predictions for Jul 2030.

In July 2030 analysts predict a stock price of $139.12. An increase of 133.65% compared to the previous month's estimate.

Tandem Diabetes Care Stock Predictions for Aug 2030.

In August 2030 analysts predict a stock price of $140.34. An increase of 135.7% compared to the previous month's estimate.

Tandem Diabetes Care Stock Predictions for Sep 2030.

In September 2030 analysts predict a stock price of $141.55. An increase of 137.74% compared to the previous month's estimate.

Tandem Diabetes Care Stock Predictions for Oct 2030.

In October 2030 analysts predict a stock price of $142.77. An increase of 139.79% compared to the previous month's estimate.

Tandem Diabetes Care Stock Predictions for Nov 2030.

In November 2030 analysts predict a stock price of $143.99. An increase of 141.84% compared to the previous month's estimate.

Tandem Diabetes Care Stock Predictions for Dec 2030.

In December 2030 analysts predict a stock price of $145.21. An increase of 143.88% compared to the previous month's estimate.

Company Info

P/E Ratio
0.0
Beta
0.78
Price-to-book Ratio
8.51
Market Cap
3.82B
TEV
4.198 B
LT Debt/Cap
0.05%
Dividend
$0.00
Div Yld
0.00%
Forecast 1Y
0.00%
Forecast 2Y
0.00%
Analyst Price Target
$127.93

About Tandem Diabetes Care

Tandem Diabetes Care, Inc., a medical device company, designs, develops, and commercializes various products for people with insulin-dependent diabetes in the United States and internationally.

Tandem Diabetes Care Price Chart

1M 3M YTD 1Y 2Y 5Y 10Y 20Y
P/E Ratio
0.0
Beta
0.78
Price-to-book Ratio
8.51
Market Cap
3.82B
TEV
4.198 B
LT Debt/Cap
0.05%
Dividend
$0.00
Div Yld
0.00%
Forecast 1Y
0.00%
Forecast 2Y
0.00%
Analyst Price Target
$127.93

Financials

Year Year TTM 2020 2021
Rev. Revenue
N/A 498.83 702.80
GM % Gross Margin %
N/A 52.2 53.5
OI Operating Income
N/A -7.96 22.65
OM Operating Margin
N/A -1.60 3.22
NI Net Income
N/A -34.38 15.57
EPS % Earnings Per Share %
N/A -0.56 0.24
Div. Dividends
N/A 0.00 0.00
PR % Payout Ratio %
N/A 0 0
Sha. Shares
N/A 62 64
OCF Operating Cash Flow
N/A 25 111
CS Cap Spending
N/A -27 -14
FCF Free Cash Flow
N/A -3 97
FCFS Free Cash Flow Per Share
N/A -0.13 1.39

Tandem Diabetes Care Analyst Ratings Frequently Asked Questions

Who are the analysts watching Tandem Diabetes Care, Inc.?

The following analysts have recently covered Tandem Diabetes Care:

Baird
Barclays
CFRA Equity Research
CGS-CIMB / CIMB Research
Citigroup Inc
Citigroup Inc. Research
Cowen and Company
Craig-Hallum Capital Group LLC
Lake Street Capital Markets, LLC
Oppenheimer & Co. Inc.
Piper Sandler Companies
Raymond James & Associates
Stifel
Wells Fargo Securities, LLC
Marktfeld
BofA Global Research
(This information refers to the last 90 days.)

Who are the sell-side analysts watching Tandem Diabetes Care, Inc.?

The following sell-side analysts have recently covered Tandem Diabetes Care:

Johnson, Jeffrey D.
Steed, Travis Lee
Bedford, Jayson Tyler
Wuensch, Joanne Karen
Jennings, Joshua Thomas
Nowak, Alexander David
O'Neil, Brooks Gregory
Lichtman, Steven Michael
O'Brien, Matthew Oliver
Blackman, Mathew Justin
Biegelsen, Lawrence H.
Paraskevopoulos, Michail
Elliott, Michael
(This information refers to the last 90 days.)

© Copyright 2022 | TopGraphs™ | All Rights Reserved

To use TopGraphs™, you must accept our Terms and Conditions and Privacy Policy